Issues - Dicembre 2024

Immune checkpoint inhibitors for patients with metastatic triple-negative inflammatory breast cancer (INCORPORATE): An international cohort study

Simonpietro Marrocco Issues, Dicembre 2024

Leggi abstract

---

van ‘t Veer LJ, Meershoek-Klein Kranenbarg E, Duijm-de Carpentier M, et al.

Selection of patients with early-stage breast cancer for extended endocrine therapy: a secondary analysis of the IDEAL randomized clinical trial

JAMA Netw Open 2024;7(11):e2447530

Simonpietro Marrocco Issues, Dicembre 2024

Leggi abstract

---

Melink Z, Lustberg MB, Schnell PM, et al.

Effect of minocycline on changes in affective behaviors, cognitive function, and inflammation in breast cancer survivors undergoing chemotherapy: a pilot randomized controlled trial

Breast Cancer Res Treat 2024;208(3):605-617

Simonpietro Marrocco Issues, Dicembre 2024

Leggi abstract

---

Awan AA, Stober C, Pond GR, et al.

A randomised trial comparing 6-monthly adjuvant zoledronate with a single one-time dose in patients with early breast cancer

Breast Cancer Res Treat 2024;208(3):523-533

Simonpietro Marrocco Issues, Dicembre 2024

Leggi abstract

---

Phillips KA, Kotsopoulos J, Domchek SM, et al.

Hormonal contraception and breast cancer risk for carriers of germline mutations in BRCA1 and BRCA2

J Clin Oncol 2024 Oct 2:JCO2400176. Epub ahead of print

Simonpietro Marrocco Issues, Novembre 2024

Leggi abstract | Scarica ppt

---

Wu AH, Wu J, Tseng C, et al.

Air pollution and breast cancer incidence in the multiethnic cohort study

J Clin Oncol 2024 Oct 8:JCO2400418. Epub ahead of print

Simonpietro Marrocco Issues, Novembre 2024

Leggi abstract | Scarica ppt

---

Kim DH, Théberge V, Parpia S, et al.

OPAR: a randomized trial of partial breast irradiation in five fractions once daily for early breast cancer

J Clin Oncol 2024 Oct 8:JCO2400600. Epub ahead of print

Simonpietro Marrocco Issues, Novembre 2024

Leggi abstract | Scarica ppt

---

Turner N, Saura C, Aftimos p, et al.

Trastuzumab duocarmazine in pretreated human epidermal growth factor receptor 2-positive advanced or metastatic breast cancer: an open-label, randomized, phase III trial (TULIP)

J Clin Oncol 2024 Oct 23:JCO2400529. Epub ahead of print

Simonpietro Marrocco Issues, Novembre 2024

Leggi abstract | Scarica ppt

---

Jensen MB, Balslev E, Knoop AS, et al.

Adjuvant docetaxel and cyclophosphamide with or without epirubicin for early breast cancer: final analysis of the randomized DBCG 07-READ trial

J Clin Oncol 2024 Oct 23:JCO2400836. Epub ahead of print

Simonpietro Marrocco Issues, Novembre 2024

Leggi abstract | Scarica ppt

---

Hortobagyi GN, Lacko A, Sohn J, et al.

A phase III trial of adjuvant ribociclib plus endocrine therapy vs endocrine therapy alone in patients with HR+/HER2- early breast cancer: final invasive disease-free survival results from the NATALEE trial

Ann Oncol 2024 Oct 21:S0923-7534(24)04064-X. Epub ahead of print

Simonpietro Marrocco Issues, Novembre 2024

Leggi abstract

---

Hiensch AE, Depenbusch J, Schmidt ME, et al.

Supervised, structured and individualized exercise in metastatic breast cancer: a randomized controlled trial

Nat Med 2024;30(10):2957-2966

Simonpietro Marrocco Issues, Novembre 2024

Leggi abstract

---

Watts EL, Moore SC, Abar L, et al.

Physical activity, metabolites, and breast cancer associations

J Natl Cancer Inst 2024 Oct 9:djae246. Epub ahead of print

Simonpietro Marrocco Issues, Novembre 2024

Leggi abstract

---

John EM, Koo J, Ingles SA, et al.

Risk factors for second primary breast cancer by laterality, age, and race and ethnicity

J Natl Cancer Inst 2024 Oct 11:djae254. Epub ahead of print

Simonpietro Marrocco Issues, Novembre 2024

Leggi abstract

---

• ← Previous
• Next →